Skip to main content

ADVERTISEMENT

Brian R. Clapp, MA, PhD

05/20/2014
We report the case of a patient who developed refractory CS during elective PCI and was successfully managed with concomitant use of IABP and the Impella 2.5 L support device.
We report the case of a patient who developed refractory CS during elective PCI and was successfully managed with concomitant use of IABP and the Impella 2.5 L support device.
We report the case of a patient...
05/20/2014
Journal of Invasive Cardiology
Original Contribution
07/27/2022
Guidelines endorse a heart team (HT) approach to standardize the decision-making process for patients with complex coronary artery disease (CAD). With percutaneous treatment options for complex CAD increasing, we hypothesized that practice...
Guidelines endorse a heart team (HT) approach to standardize the decision-making process for patients with complex coronary artery disease (CAD). With percutaneous treatment options for complex CAD increasing, we hypothesized that practice...
Guidelines endorse a heart team...
07/27/2022
Journal of Invasive Cardiology